Finding biomarkers in children after heart surgery
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at proteins in the blood that may help doctors understand how children are recovering after heart surgery. It enrolls children under age 5 having certain types of heart repairs at Boston Children's Hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your parent or guardian must agree (give consent) to let you be in the study.
- You must be between 1 and 5 years old, and scheduled for a heart repair called elective BiV repair.
- Or, you are having a standard risk surgery known as S1P or ASO.
- You must not be on a breathing machine (ventilator) or receiving strong heart-supporting medicines before surgery.
- You must not be on ECMO (heart-lung bypass machine) before the operation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new, non-invasive way to measure hemoglobin (the part of blood that carries oxygen) using a light sensor on the skin, without needing extra blood draws. The goal is to see if this sensor is accurate for children having heart procedures, which could reduce the number of needle sticks they need.
This study looks at tiny particles from cells in newborns with heart defects to understand blood clot risks. It aims to find ways to prevent clots after heart surgery.
This study collects and analyzes small samples of heart tissue during specific heart operations in babies or children. The goal is to better understand how the heart develops after birth, which could improve future care.
This study tests a special sensor (near-infrared spectroscopy) that checks blood flow to the heart and other organs during heart surgery. It may help doctors monitor and improve care for children having complex heart procedures.
This trial is testing a way to help doctors assess babies and children with congenital heart disease and heart failure before placing a temporary heart support pump. It may help improve planning by using heart scans to decide who needs support and how to prepare.
This trial studies patterns in immune cells (neutrophils) in very young children who undergo heart surgery using a heart-lung machine. The goal is to better understand and potentially reduce lung injury after surgery.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.